Biofrontera Inc. (BFRIW)

0.08

0.02 (37.93%)

At close: Mar 04, 2025, 10:12 AM

Biofrontera Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-20.13M	-640K	-37.71M	-10.99M	-10.98M
Depreciation & Amortization	1.06M	1.17M	540K	562K	667K
Stock-Based Compensation	1.04M	1.85M	129K	n/a	n/a
Other Working Capital	-11.99M	4.76M	-2.71M	-321K	-21.08M
Other Non-Cash Items	-2.48M	-21.37M	-1.04M	883K	-3.42M
Deferred Income Tax	n/a	n/a	12.88M	n/a	n/a
Change in Working Capital	-4.39M	2.79M	-1.5M	-2.83M	-23.94M
Operating Cash Flow	-24.89M	-16.2M	-26.71M	-12.37M	-37.68M
Capital Expenditures	-5K	-38K	-11K	n/a	-538K
Acquisitions	n/a	n/a	n/a	n/a	25.93M
Purchase of Investments	n/a	-5.12M	n/a	n/a	n/a
Sales Maturities Of Investments	624K	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-5.12M	n/a	n/a	n/a
Investing Cash Flow	619K	-5.16M	-11K	n/a	25.39M
Debt Repayment	3.9M	n/a	n/a	8.79M	13.5M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	4.63M	13.25M	4.4M	2.9M
Financial Cash Flow	8.41M	14.02M	43.19M	13.19M	16.4M
Net Cash Flow	-15.87M	-7.33M	16.46M	825K	4.12M
Free Cash Flow	-24.9M	-16.24M	-26.73M	-12.37M	-38.22M